RMTI plans to buy Vantive's global hemodialysis business, closing targeted mid-2027
RMTI plans to buy Vantive's global hemodialysis unit for $125M, with projected annual revenue of $400M–$450M and closing expected mid-2027, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, RMTI plans to acquire Vantive's global hemodialysis business. The deal would add machines, concentrates, water systems and services to its portfolio. Projected annual revenue is between $400M and $450M.
The base price is $125M. Seller-backed term loans and a convertible note will finance the purchase. Closing is expected in mid-2027, subject to approvals and other conditions.
why it matters
The deal concerns a single company and a niche medical segment, so its effect on the broader market is limited. Investors may watch the closing timeline, regulatory approvals and the terms of the seller financing.
tags
instruments
sources
- RMTI: Vantive deal adds global HD scale, with mid-2027 closing targeted — TradingView, 3 November 2026 at 23:17 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗